Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biodesix, Inc. (BDSX)
:BDSX
BDSX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.86 - $2.04
Previous CloseN/A
Volume171.18K
Average Volume (3M)431.33K
Market Cap
$141.13M
Enterprise Value$290.86M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Mar 03, 2025EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding145,467,300
10 Day Avg. Volume254,819
30 Day Avg. Volume431,328
Standard Deviation0.23
R-Squared0.05
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.10
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market Cap2.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.06
Enterprise Value/Ebitda-9.82
Forecast
1Y Price Target
$3.00Price Target Upside219.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Biodesix News
PremiumCompany Announcements
Biodesix Reports Strong Q3 2024 Growth in Diagnostics
---
Bulls Say, Bears Say
Bulls Say
Revenue GuidanceBiodesix believes its 4Q24 performance should be stronger, as the company reaffirmed its 2024 revenue guidance.
Sales Force ExpansionSales force expansion should drive continued growth, with the company adding multiple sales representatives in 3Q24.
Bears Say
Revenue PerformanceThird-quarter revenues were below estimates due to weather impacts and delays in sales representative hiring.
Weather ImpactBiodesix's performance was negatively impacted by severe hurricanes that recently occurred in the Southeast region of the U.S.
---
Ownership Overview
49.43% Insiders
2.72% Mutual Funds
0.24% Other Institutional Investors
45.01% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BDSX FAQ
What was Biodesix, Inc.’s price range in the past 12 months?
Biodesix, Inc. lowest stock price was $0.86 and its highest was $2.04 in the past 12 months.
What is Biodesix, Inc.’s market cap?
Biodesix, Inc.’s market cap is $141.13M.
When is Biodesix, Inc.’s upcoming earnings report date?
Biodesix, Inc.’s upcoming earnings report date is Mar 03, 2025 which is in 10 days.
How were Biodesix, Inc.’s earnings last quarter?
Biodesix, Inc. released its earnings results on Nov 01, 2024. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.073 by $0.003.
Is Biodesix, Inc. overvalued?
According to Wall Street analysts Biodesix, Inc.’s price is currently Undervalued.
Does Biodesix, Inc. pay dividends?
Biodesix, Inc. does not currently pay dividends.
What is Biodesix, Inc.’s EPS estimate?
Biodesix, Inc.’s EPS estimate is -0.07.
How many shares outstanding does Biodesix, Inc. have?
Biodesix, Inc. has 145,467,300 shares outstanding.
What happened to Biodesix, Inc.’s price movement after its last earnings report?
Biodesix, Inc. reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.073. Following the earnings report the stock price went down -23.529%.
Which hedge fund is a major shareholder of Biodesix, Inc.?
Currently, no hedge funds are holding shares in BDSX
---
Biodesix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (219.15% Upside)
$3.00 (219.15% Upside)
Blogger Sentiment
Bullish
BDSX Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $396.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.25%
12-Months-Change
Fundamentals
Return on Equity
-331.82%
Trailing 12-Months
Asset Growth
18.39%
Trailing 12-Months
Company Description
Biodesix, Inc.
Biodesix Inc is a data-driven diagnostic solutions company. The company's artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The revenue is derived from two sources namely, providing diagnostic tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development and testing services.
---
BDSX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlights Biodesix's strong revenue growth and high gross margins, driven by success in lung diagnostic testing and an increase in biopharma services contracts. However, challenges such as the impact of hurricanes on sales, a decline in biopharma services revenue, and increased operating expenses were noted. The company remains confident in achieving its full-year revenue guidance and future profitability.Read More>---
BDSX Stock 12 Month Forecast
Average Price Target
$3.00
▲(219.15% Upside)
Technical Analysis
Best Analysts Covering BDSX
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-53.37%
reiterated a buy rating 4 months ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -53.37% per trade.
---